- Location
glycemic control
"-
Afrezza Hopes That Its Inhalable Insulin Product Will Be a Gamechanger for Diabetics
Apr 8, 2014Afrezza hopes that its inhalable insulin product will be a gamechanger for diabetics. (Image courtesy Afrezza). Insulin injections may soon be a thing of the past if Mannkind Corp.'s inhalable insulin product, Afrezza, is approved by ...
-
GlaxoSmithKline Says It Received a Positive Opinion in Europe for Albiglutide
Feb 10, 2014LONDON, Jan. 26 (UPI) -- GlaxoSmithKline says it received a positive opinion in Europe for albiglutide, under the brand name Eperzan, for treatment of type 2 diabetes. GSK officials said the Committee for Medicinal Products for Human Use ...
Tags: Albiglutide, Glaxosmithkline, FDA
-
Gastric Bypass Surgery Is a Type of Bariatric Operation Such as Diabetes
Jan 10, 2014Interview conducted by April Cashin-Garbutt, BA Hons (Cantab) What is gastric bypass surgery and how many people undergo it? Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic ...
Tags: Interview, gastric bypass surgery, cardiovascular disease
-
Sanofi Has Released Results of a 24-Week Phase Iiib Clinical Trial
Dec 9, 2013Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...
Tags: Diabetes Drug, Medicine
-
Echo Therapeutics Has Reported Positive Results
Nov 29, 2013Echo Therapeutics, a medical device company, has reported positive results from its clinical trial of the Symphony CGM wireless continuous glucose monitoring system in surgical patients in hospital critical care units. Echo Therapeutics ...
-
The Benefits Come From Monounsaturated Fats Provided by Liberal Use of Olive Oil.
Nov 19, 2013Followers of the popular Mediterranean diet have known for years that eating fresh fruits and vegetables, nuts, seeds and plenty of extra virgin olive oil is beneficial to health. Recent studies have continued to bolster this eating ...
-
Glysure Completes Patient Enrollment for The Multicenter CE Mark Trial of CBGM System
Nov 1, 2013UK-based GlySure has completed patient enrollment for the multicenter CE Mark trial of its in-hospital continuous blood glucose monitoring (CBGM) system. The trial, led by principal investigator Dr Krishna Prasad, comprised 30 post ...
Tags: CE Mark Trial, Glysure
-
MannKind Has Resubmitted a New Drug Application to The FDA
Oct 16, 2013US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...
Tags: Insulin Application, biopharmaceutical company MannKind
-
Integrity Applications Has Received CE Mark for Glucotrack DF-F Non-Invasive Device
Jun 7, 2013Integrity Applications, an Israel-based medical device company, has received CE Mark approval for its GlucoTrack DF-F non-invasive device. The GlucoTrack DF-F is a glucose measuring device that uses a patented combination of ultrasound, ...
-
Mitsubishi Tanabe Pharma Is Seeking Manufacturing and Marketing Approval of TA-7284
May 27, 2013Mitsubishi Tanabe Pharma is seeking manufacturing and marketing approval of TA-7284 (generic name: canagliflozin) in Japan. The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to ...
Tags: Mitsubishi, canagliflozin
-
FDA Has Approved Janssen's Invokana for The Treatment of Adults
Apr 2, 2013The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
-
CeQur Has Reported Its PaQ Insulin Delivery Device Initial Study Data
Mar 6, 2013CeQur has reported its PaQ insulin delivery device initial study data at the 6th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Paris, France. The discreet, wearable CE-marked device, which comprises ...
Tags: CeQur, PaQ insulin delivery device, insulin infuser reservoir
-
The USFDA Has Issued Final Approval to Manufacture and Market Aurobindo Pharma's Diabetes
Feb 19, 2013The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...
Tags: USFDA, Aurobindo Pharma, diabetes drugs
-
CE Mark Is Won by Hygieia's New Diabetes Insulin Guidance System
Dec 18, 2012The European Union has granted CE mark to Hygieia's new diabetes insulin guidance system (DIGS), designed for insulin treated patients with poor glycemic control. The d-Nav system automatically updates insulin dosage as needed and ...
Tags: Hygieia, DIGS, CE mark, diabetes insulin guidance system, glycemic control
-
CeQur Has Started a Clinical Study of PaQ Insulin Delivery Device
Dec 18, 2012CeQur, a developer of wearable delivery devices, has started a clinical study of PaQ insulin delivery device. The PaQ study is conducted by Thomas Pieber, head of endocrinology and metabolism division at Austria University Hospital. The ...
Tags: CeQur, clinical study, PaQ insulin delivery device, PaQ study
![[Exclusive-Formulas] Glycemic Control Probiotic Custom Blend Premix Powders OEM/ODM](https://image.made-in-china.com/3f2j00bdlVRPYJADgy/-Exclusive-Formulas-Glycemic-Control-Probiotic-Custom-Blend-Premix-Powders-OEM-ODM.jpg "[Exclusive-Formulas] Glycemic Control Probiotic Custom Blend Premix Powders OEM/ODM")
